Target intelligence / Profile preview

DNA interstrand cross-link (null)

Target
null
Molecular classification
Other
01

Overview

DNA interstrand cross-linking is a chemical process in which covalent bonds are formed between nucleotides on opposing DNA strands, preventing their separation during replication or transcription. Such cross-links are extremely cytotoxic because they block fundamental cellular processes. While some agents capable of inducing cross-links (notably certain chemotherapeutic drugs such as alkylating agents and platinum compounds) are used clinically to kill rapidly dividing cancer cells, the inability to effectively repair these lesions in normal cells can also cause serious toxicity. DNA cross-linking can be detected and repaired through complex cellular mechanisms (notably nucleotide excision repair and homologous recombination). The efficacy of DNA cross-linking drugs in cancer therapy is offset by the risk of resistance (due to upregulated repair) and widespread adverse effects in non-cancerous tissues[1][2][5].

Other names
DNA cross-linkDNA interstrand cross-linkDNA intrastrand cross-linkDNA crosslinkingICL
02

Mechanism of action

Drugs form covalent cross-links between DNA strands, blocking DNA replication and transcription, leading to cell cycle arrest and cell death[1][2][5].

03

Biological functions

DNA damage responseCell cycle arrestApoptosis (indirect result of unrepaired cross-links)Inhibition of DNA replication and transcription
04

Disease associations

Cancer (targeted in chemotherapy)Genomic instability syndromes
05

Safety considerations

Myelosuppression, secondary malignanciesOff-target DNA damage in healthy cells leading to toxicity (bone marrow, gastrointestinal tract)Chemoresistance via increased DNA repair pathways[5]
06

Interacting drugs

Alkylating agents (e.g., nitrogen mustards: chlorambucil, cyclophosphamide)

3 more in the full profile.

07

Biomarkers

Increased DNA cross-linking as a marker of chemotherapy efficacy (but there are no specific protein/cellular biomarkers universally used for patient selection based on DNA cross-linking itself)DNA damage response pathway activation (e.g., γ-H2AX, Fanconi anemia pathway proteins)

Beyond the preview

Go deeper on DNA interstrand cross-link (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA interstrand cross-link (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call